NS Wind Down Co. Executive Compensation (FY22)
NSTG · Executive and director compensation, fiscal 2022 only
Chief executive, fiscal 2022 ◇ R. Bradley Gray | Latest say-on-pay support = June 23, 2023 | Chief executive pay ratio ◇ To the median employee |
Velarion Member: every covered company in one industry, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The NS Wind Down Co. brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Data as of October 4, 2026Latest filing (8-K): June 27, 2023
6 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Member, one year
166 figures on this page: 161 cited to the filing that reported them, 5 calculated from figures it prints. See the citations
Frequently asked questions
Answers drawn from the data on this page.
Who is NS Wind Down Co.'s chief executive and what were they paid?
R. Bradley Gray, President and Chief Executive Officer, received $7,596,268 in total compensation for fiscal 2022.
What was NS Wind Down Co.'s say-on-pay result?
Shareholders supported the say-on-pay proposal with 36.5% of votes cast including abstentions in favor at the meeting held June 23, 2023 for fiscal 2022.
Which companies are in NS Wind Down Co.'s peer group?
The disclosed peer group includes 10x Genomics, Inc., Adaptive Biotechnologies Corp., Berkeley Lights, Inc., CareDx, Inc. and Castle Biosciences, Inc., among others.
What is NS Wind Down Co.'s chief executive pay ratio?
The company reported a chief executive pay ratio of 54:1 for fiscal 2022, against median employee compensation of $141,124.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
R. Bradley Gray President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
John Gerace Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Joseph Beechem Chief Scientific Officer and Senior Vice President, Research & Development | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
K. Thomas Bailey Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
J. Chad Brown Senior Advisor (Former Senior Vice President, Sales and Marketing) Departed during or after this year | ◇ | — | — | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2022
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| John Gerace | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| John Gerace | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Joseph M. Beechem | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Joseph M. Beechem | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| K. Thomas Bailey | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| K. Thomas Bailey | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| R. Bradley Gray | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| R. Bradley Gray | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2022 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Joseph Beechem | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/24/2029 | |
| R. Bradley Gray | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/24/2029 | |
| John Gerace | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| J. Chad Brown | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/24/2029 | |
| PSU | ◇ | ◇ | — | — | |
| K. Thomas Bailey | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/24/2029 |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
R. Bradley Gray
President and Chief Executive Officer · Employment agreement
| Change-in-control multiple | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2022
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Teresa Foy | ◇ | ◇ | — | — | — | — | ◇ |
William D. Young Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Elisha W. Finney | ◇ | ◇ | — | — | — | — | ◇ |
Charles P. Waite | ◇ | ◇ | — | — | — | — | ◇ |
Gregory Norden | ◇ | ◇ | — | — | — | — | ◇ |
Janet George | ◇ | ◇ | — | — | — | — | ◇ |
Kirk D. Malloy | ◇ | ◇ | — | — | — | — | ◇ |
Dana Rollison | ◇ | ◇ | — | — | — | — | ◇ |
Robert M. Hershberg | ◇ | ◇ | — | — | — | — | ◇ |
Don R. Kania | ◇ | — | — | — | — | — | ◇ |
R. Bradley Gray served on the board in fiscal 2022 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2022
- 10x Genomics, Inc. TXG
- Adaptive Biotechnologies Corp. ADPT
- Berkeley Lights, Inc. symbol not shown
- CareDx, Inc. CDNA
- Castle Biosciences, Inc. CSTL
- Cerus Corporation CERS
- Codexis, Inc. CDXS
- Fluidigm Corp. (now Standard Biotools Inc.) symbol not shown
- Guardant Health, Inc. GH
- Invitae Corporation NVTAQ
- Meridian Bioscience, Inc. HBIO
- Natera, Inc. NTRA
- NeoGenomics, Inc. NEO
- Pacific Biosciences of California, Inc. PACB
- Personalis, Inc. PSNL
- Quanterix Corporation QTRX
- Repligen Corporation RGEN
- Seer, Inc. symbol not shown
- Twist Bioscience Corporation TWST
- Veracyte, Inc. VCYT
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2022 | June 23, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | June 17, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | June 16, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | June 16, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | June 18, 2019 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Velarion Pro: every company page, peer tools and exports, one seat
One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- R. Bradley Gray (President and Chief Executive Officer), FY2022 total compensation $7,596,268 (base salary $645,000) [exec_comp, SEC accession 0001401708-23-000096, filed 2023-04-28]What this page does not include
Everything above is a fact NS Wind Down Co. disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where NS Wind Down Co. sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceSay-on-pay responsiveness
NS Wind Down Co. recorded a low support level. The responsiveness analysis covers what the company said it would do, what it did, and how that compares with the companies that recovered their vote.
Responsiveness analysisAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
166 figures on this page: 161 cited to the filing that reported them, 5 calculated from figures it prints.
161 cited to the filing
5 calculated from the filing
Documents cited
- 0001401708-23-000159
- 0001401708-23-000096Grants of Plan-Based Awards · POTENTIAL PAYMENTS UPON TERMINATION
- 0001401708-22-000118Proposal No. 4 – Approval of the 2022 Equity Incentive Plan” in the Company’s definitive proxy statement on Schedule 14A filed with the United States Securities and Exchange Commission (the “SEC”) on
- 0001401708-21-000184
- 0001401708-20-000138
- 0001401708-19-000158
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “NS Wind Down Co. executive compensation, FY2022.” https://intel.velarion.ai/comp/NSTG (accessed 2026).
Short form: data: Velarion
The NS Wind Down Co. brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
6 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about NS Wind Down Co. and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers NS Wind Down Co. discloses
The companies named in NSTG's own disclosed peer group.
10x Genomics, Inc.Adaptive Biotechnologies Corp.CareDx, Inc.Castle Biosciences, Inc.Cerus CorporationCodexis, Inc.Guardant Health, Inc.Meridian Bioscience, Inc.Natera, Inc.NeoGenomics, Inc.Pacific Biosciences of California, Inc.Personalis, Inc.Quanterix CorporationRepligen CorporationTwist Bioscience CorporationVeracyte, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}